Want to know one of the ways we are accelerating the progress of scleroderma research? Get acquainted with CONQUEST, a phase 2b, international, multicenter, platform clinical trial developed by the SRF and partner biopharmaceutical companies to study multiple therapies for the treatment of interstitial lung disease (ILD) associated with systemic sclerosis (SSc-ILD). Present by Toby Maher MD (Professor of Clinical Medicine, Keck School of Medicine of the University of Southern California) and Dinesh Khanna, MD, MS (Professor of Medicine, University of Michigan).
- Күн бұрын
CONQUEST, a Platform Clinical Trial
- Рет қаралды 584
Пікірлер